A federal judge has thrown out a subpoena that generated opposition from the John Locke Foundation and other defenders of free speech. The subpoena had targeted nonprofit groups working on a high-profile public policy debate in Alabama.
These Subpoenas Targeting Opponents Of Chemical Castration Prove Biden Is The Real Culture War Villain freerepublic.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from freerepublic.com Daily Mail and Mail on Sunday newspapers.
Agriculture
your username
May 7, 2021
Plaintiff John Carsonâs Wednesday filing alleged that the lower court wrongly determined that his Georgia law failure-to-warn claim against Monsanto Company met both criteria for preemption by the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). The 2017 lawsuit claimed that using Roundup on his lawn for three decades caused Carson to develop malignant fibrous histiocytoma, a type of cancer.
The brief explained that within the last decade, health organizations have determined that glyphosate, the herbicideâs main ingredient, is a probable cause of cancer. The plaintiff claimed that Monsanto has known about the risk for decades but has nevertheless falsely promoted the productâs safety.
Agriculture
your username
April 29, 2021
In response to allegations that it paid John Carson to appeal a lawsuit filed against Monsanto, a subsidiary of Bayer AG to the Eleventh Circuit, asked the appellate court to allow it to file the actual agreement between it and the plaintiff under seal in an unopposed motion on Wednesday, claiming that it was represented poorly to the court.
The allegations were filed in the matter on April 22 by plaintiffs involved in similar lawsuits in other courts against Monsanto regarding its Roundup herbicide and alleged harm caused by its active ingredient, glyphosate. These plaintiffs alleged that Bayer paid Carson to appeal the lawsuit because the Southern District of Georgia decided to dismiss some of the plaintiffs’ claims and Bayer wants that decision to apply to some of the other lawsuits against it, where it could save them even more money. The third-party plaintiffs alleged that this is improper and that the Eleventh Circuit should be a